297 related articles for article (PubMed ID: 15205218)
1. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
3. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
Packard CJ; O'Reilly DS; Caslake MJ; McMahon AD; Ford I; Cooney J; Macphee CH; Suckling KE; Krishna M; Wilkinson FE; Rumley A; Lowe GD
N Engl J Med; 2000 Oct; 343(16):1148-55. PubMed ID: 11036120
[TBL] [Abstract][Full Text] [Related]
5. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
[TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
[TBL] [Abstract][Full Text] [Related]
9. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
Wu T; Rifai N; Willett WC; Rimm EB
Am J Epidemiol; 2007 Sep; 166(5):544-51. PubMed ID: 17615090
[TBL] [Abstract][Full Text] [Related]
10. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
[TBL] [Abstract][Full Text] [Related]
12. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
[TBL] [Abstract][Full Text] [Related]
13. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease.
von Känel R; Dimsdale JE; Ancoli-Israel S; Mills PJ; Patterson TL; McKibbin CL; Archuleta C; Grant I
J Am Geriatr Soc; 2006 Mar; 54(3):431-7. PubMed ID: 16551309
[TBL] [Abstract][Full Text] [Related]
14. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
[TBL] [Abstract][Full Text] [Related]
15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
16. Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Ekström M; Silveira A; Bennermo M; Eriksson P; Tornvall P
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):473-7. PubMed ID: 17581323
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
Assmann G; Cullen P; Heinrich J; Schulte H
Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
[TBL] [Abstract][Full Text] [Related]
18. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
Pascual DA; Arribas JM; Tornel PL; Marín F; Oliver C; Ahumada M; Gomez-Plana J; Martínez P; Arcas R; Valdes M
Ann Thorac Surg; 2006 Jan; 81(1):78-83. PubMed ID: 16368340
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
[TBL] [Abstract][Full Text] [Related]
20. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]